CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
CLOVER HEALTH INVESTMENTS, CORP. /DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$4.44−0.04 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $2.42B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.73 (+63.84%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CLOVER HEALTH INVESTMENTS, CORP. /DE grew revenue 54.0% to $2.48B over the twelve months to Jun 30, 2026. Free cash flow was $74.21M.
Revenue
$2.48B
+54.0% vs. a year earlier
Operating income
-$18.36M
TTM Q2 2026
Free cash flow
$74.21M
TTM Q2 2026
EPS, diluted
-$0.05
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.42B
- P/E ratio
- –
- Price to sales
- 0.98
- Price to book
- 6.44
- Dividend yield
- –
- Free cash flow yield
- 3.06%
Fundamentals
- Revenue
- $2.48B
- Net income
- -$18.36M
- EPS, diluted
- -$0.05
- Free cash flow
- $74.21M
- Book value per share
- $0.69
- Diluted shares
- 545M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$2.48B+54.0% YoY
Gross profit
–
Operating income
-$18.36M
Net income
-$18.36M
EPS, diluted
-$0.05
Free cash flow
$74.21M
Reported periodTrailing twelve months